A new modelling study reveals that only 7% of carbapenem-resistant Gram-negative (CRGN) bacterial infections in eight LMICs receive effective antibiotic treatment. This stark undertreatment poses a major threat in the global fight against antimicrobial resistance (AMR).
Most deadly drug-resistant infections in poorer countries go untreated, study shows
- Post author:admin
- Post published:May 7, 2025
- Post category:uncategorized